Testosterone aromatizes to estradiol and converts to DHT; producing both estrogenic and androgenic effects alongside its anabolic activity. Stanozolol is resistant to aromatization and has a comparatively suppressed androgenic response relative to its anabolic activity; patients who experience unwanted estrogenic effects or sensitivity to high androgenic activity from testosterone protocols may respond differently to Stanozolol's distinct hormonal profile.
As with all anabolic therapies at RegenMD, physician supervision, protocol monitoring, and regular provider check-ins are central components of the program.